VERDI Solutions GmbH

VERDI Solutions is personalizing cancer immunotherapy—designing vaccines for each patient and delivering them as a service. We develop individualized peptide vaccines based on each patient’s unique tumor and immune profile. Our proprietary VERDI System combines AI, immune topology analysis, and bioinformatics to identify actionable targets and select immunogenic peptides. What makes us unique? Our vaccine development algorithm not only predicts safety, immunogenicity, and efficacy—it also ensures that each vaccine is manufacturable to the highest quality standards. We don’t sell drugs—we deliver outcomes. Through our Oncology-as-a-Service (OaaS) model, we enable the decentralized delivery of personalized cancer treatment. Working with expert oncologists, sequencing labs, and manufacturing partners, we ensure VERDI vaccines are accessible, rapidly produced, and smoothly integrated into patient care. Backed by real-world data and evidences, VERDI is personalizing oncology—where every patient receives a therapy designed just for them. At the heart of VERDI Solutions GmbH is our unwavering commitment to scientific excellence, patient safety, and treatment efficacy. We envision a world where personalized cancer therapies are smoothly delivered and readily available, transforming the future of oncology care for patients everywhere.